Home » Topics » BioWorld Science

BioWorld Science
RSS

MIF may contribute to disseminated coccidioidomycosis susceptibility

Oct. 10, 2019

New phase I study evaluates birinapant and radiation therapy in head and neck cancer

Oct. 10, 2019

DSMB recommends continuation of phase IIa study of montelukast VersaFilm in Alzheimer's disease

Oct. 10, 2019

FDA approves PF-708 for osteoporosis

Oct. 10, 2019

AgenTus Therapeutics develops T-cell receptor candidate targeting NY-ESO-1

Oct. 10, 2019

Affimed Therapeutics divulges EGFR- and CD16A-targeting proteins

Oct. 10, 2019

Evelo Biosciences presents new Tyzzerella nexilis bacterial compositions

Oct. 10, 2019

Beijing Tide Pharmaceutical synthesizes AGTR2 antagonists

Oct. 10, 2019

Roche divulges new MGL inhibitors

Oct. 10, 2019

Chinese investigators patent ROCK inhibitors

Oct. 10, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...